More importantly, a research conducted by Nakashima-Nakasuga et al. elucidated that CRC patients with high OLR1 expression in tumor tissues showed obviously poorer prognosis than individuals with low expression [31]. The gene discussed is OLR1; the disease is colorectal carcinoma.